Clinical predictors of fulminant colitis in patients with Clostridium difficile infection

Saudi Journal of Gastroenterology

Volumn 18, Issue 2, 2012, Pages 133-139

  Girotra, Mohit ^a   Kumar, Vivek ^b   Khan, Javaid ^a   Damisse, Pamela ^a   Abraham, Rtika ^a   Aggarwal, Vikas ^c   Dutta, Sudhir ^d,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

Clostridium difficile; colitis; fulminant; predictors

Indexed keywords

PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; AGED; ARTICLE; CHI SQUARE TEST; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON DILATATION; COLON RESECTION; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; FEMALE; HEMODYNAMICS; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STUDENT T TEST; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; COLITIS; COMORBIDITY; DIARRHEA; DISEASE PROGRESSION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84858977956     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.93820     Document Type: Article

References (28)

1. Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery 2008;143:623-9.
2. Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: A French multicenter study. Arch Intern Med 1996;156:1449-54. (Pubitemid 26226940)
3. Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, et al. Fulminant Clostridium difficile colitis: Patterns of care and predictors of mortality. Arch Surg 2009;144:433-9.
4. Seder CW, Villalba MR Jr, Robbins J, Ivascu FA, Carpenter CF, Dietrich M, et al. Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: An 8-year experience. Am J of Surg 2009;197:302-7.
5. Efron P, Mazuski JE. Clostridium difficile colitis. Surg Clin North Am 2009;89:483-500.
6. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9. (Pubitemid 41770165)
7. Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg 2008;143:150-4; discussion 155.
8. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short stay hospitals, 1996-2003. Emerg Infect Dis 2006;12:409-15.
9. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46 Suppl 1:S12-8. (Pubitemid 351323661)
10. Wysowski DK. Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002. Public Health Rep 2006;121:361-2. (Pubitemid 44186393)
11. Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum 2004;47:1620-6. (Pubitemid 39331972)
12. Lamontagne F, Labbe AC, Haeck O. Impact of emergent colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by hypervirulent strain. Ann Surg 2007;242:267-72. (Pubitemid 46148486)
13. Jaber MR, Olafsson S, Fung WL, Reeves ME. Clinical review of the management of fulminant Clostridium difficile infection. Am J of Gastroenterol 2008;103:3195-203.
14. Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: A plea for early surgical management. Am J Surg 2008;196:384-8.
15. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72. (Pubitemid 34183887)
16. Grundfest-Broniatowski S, Quader M, Alexander F, Walsh RM, Lavery I, Milsom J. Clostridium difficile colitis in the critically ill. Dis Colon Rectum 1996;39:619-23. (Pubitemid 26181126)
17. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991- 2003: A changing pattern of disease severity. CMAJ 2004;171:466-72. (Pubitemid 39179608)
18. Keven K, Basu A, Re L, Tan H, Marcos A, Fung JJ, et al. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis 2004;6:10-4. (Pubitemid 38954922)
19. Wanahita A, Goldsmith EA, Marino BJ, Musher DM. Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med 2003;115:543-6. (Pubitemid 37352800)
20. st ed. Philadelphia: W.B Saunders Co; 2000. p. 919-33.
21. Gerding DN, Johnson S, Peterson LR. Clostridium difficile associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995; 16:459-77.
22. Jaber MR, Olafsson S, Fung WL, Reeves ME. Clinical review of management of fulminant Clostridium difficile infection. Am J Gastroenterol 2008;103:3195-203.
23. Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment Pharmacol Ther 2009;29:626-34.
24. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric-acid suppressive agents and the risk of community acquired Clostridium difficile associated disease. JAMA 2005;294:2989-95. (Pubitemid 41817660)
25. Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170:784-90.
26. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008;62:388-96. (Pubitemid 351984787)
27. Nerandzic MM, Pultz MJ, Donskey CJ. Examination of potential mechanisms to explain the association between Proton pump inhibitors and Clostridium difficile infection. Antimicrob Agents Chemother 2009;53:4133-7.
28. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995;38:350-4.